Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy

被引:142
作者
Li, BSY
Wang, H
Gonen, O
机构
[1] NYU, Sch Med, Dept Radiol, New York, NY 10016 USA
[2] Fox Chase Canc Ctr, Dept Biostat, Philadelphia, PA 19111 USA
关键词
brain; metabolite concentration; metabolite-ratio; quantification; proton MR spectroscopy (H-1-MRS);
D O I
10.1016/S0730-725X(03)00181-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
In localized brain proton MR spectroscopy (H-1-MRS), metabolites' levels are often expressed as ratios, rather than as absolute concentrations. Frequently, their denominator is the creatine [Cr], which level is explicitly assumed to be stable in normal as well as in many pathologic states. The rationale is that ratios self-correct for imager and localization method differences, gain instabilities, regional susceptibility variations and partial volume effects. The implicit assumption is that these benefits are worth their cost(w)-(w) propagation of the individual variation of each of the ratio's components. To test this hypothesis, absolute levels of N-acetylaspartate [NAA], choline [Cho] and [Cr] were quantified in various regions of the brains of 8 volunteers, using 3-dimensional (3D) H-1-MRS at 1.5 T. The results show that in over 50% of similar to2000 voxels examined, [NAA]/[Cr] and [Cho]/[Cr] exhibited higher coefficients of variations (CV) than [NAA] and [Cho] individually. Furthermore, in similar to33% of these voxels, the ratios' CVs exceeded even the combined constituents' CVs. Consequently, basing metabolite quantification on ratios and assuming stable [Cr] introduces more variability into H-1-MRS than it prevents. Therefore, its cost exceeds the benefit. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:923 / 928
页数:6
相关论文
共 27 条
[21]   Representation of strong baseline contributions in 1H MR spectra [J].
Soher, BJ ;
Young, K ;
Maudsley, AA .
MAGNETIC RESONANCE IN MEDICINE, 2001, 45 (06) :966-972
[22]   1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS [J].
Suhy, J ;
Rooney, WD ;
Goodkin, DE ;
Capizzano, AA ;
Soher, BJ ;
Maudsley, AA ;
Waubant, E ;
Andersson, PB ;
Weiner, MW .
MULTIPLE SCLEROSIS JOURNAL, 2000, 6 (03) :148-155
[23]   Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis [J].
Tartaglia, MC ;
Narayanan, S ;
De Stefano, N ;
Arnaoutelis, R ;
Antel, SB ;
Francis, SJ ;
Santos, AC ;
Lapierre, Y ;
Arnold, DL .
JOURNAL OF NEUROLOGY, 2002, 249 (10) :1382-1390
[24]   Hippocampal structures:: Anteroposterior N-acetylaspartate differences in patients with epilepsy and control subjects as shown with proton MR spectroscopic imaging [J].
Vermathen, P ;
Laxer, KD ;
Matson, GB ;
Weiner, MW .
RADIOLOGY, 2000, 214 (02) :403-410
[25]   CHEMICAL-SHIFT IMAGING OF HUMAN BRAIN - AXIAL, SAGITTAL, AND CORONAL P-31 METABOLITE IMAGES [J].
VIGNERON, DB ;
NELSON, SJ ;
MURPHYBOESCH, J ;
KELLEY, DAC ;
KESSLER, HB ;
BROWN, TR ;
TAYLOR, JS .
RADIOLOGY, 1990, 177 (03) :643-649
[26]   A fully automated method for tissue segmentation and CSF-correction of proton MRSI metabolites corroborates abnormal hippocampal NAA in schizophrenia [J].
Weber-Fahr, W ;
Ende, G ;
Braus, DF ;
Bachert, P ;
Soher, BJ ;
Büchel, C .
NEUROIMAGE, 2002, 16 (01) :49-60
[27]   Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder [J].
Winsberg, ME ;
Sachs, N ;
Tate, DL ;
Adalsteinsson, E ;
Spielman, D ;
Ketter, TA .
BIOLOGICAL PSYCHIATRY, 2000, 47 (06) :475-481